Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
PLoS One ; 17(1): e0262649, 2022.
Article in English | MEDLINE | ID: mdl-35061811

ABSTRACT

Vaccination is a major strategy to prevent the coronavirus disease 2019 (COVID-19). However, information about factors associated with men and women intention to be vaccinated are scarce. To determine COVID-19 vaccine acceptance and identify factors associated vaccine hesitancy according to sex, we performed a cross-sectional population-based random survey in Salvador, Brazil between Nov/2020-Jan/2021. Participants were interviewed to obtain data on intention to receive and pay for a COVID-19 vaccine, as well as on demographics, comorbidities, influenza vaccination history, previous diagnosis of COVID-19, and exposures and perception of COVID-19 risk. Among 2,521 participants, 2,053 (81.4%) reported willingness to use a COVID-19 vaccine and 468 (18.6%) hesitated to take it. Among those intending to get vaccinated, 1,400 (68.2%) would pay for the vaccine if necessary. Sex-stratified multivariable analysis found that men who were working and who had comorbidities were less likely to hesitate about using the vaccine. Among women, higher educational level and high perception of COVID-19 risk were associated with less vaccine hesitancy. In both groups, reporting influenza vaccination in 2020 reduced the chance of COVID-19 vaccine hesitancy. COVID-19 vaccine campaigns targeting to reduce vaccine hesitancy are urgently needed. These campaigns should consider gender differences in order to be successful.


Subject(s)
COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , SARS-CoV-2/pathogenicity , Vaccination Hesitancy/psychology , Vaccination/psychology , Adult , Aged , Brazil/epidemiology , COVID-19/epidemiology , Cross-Sectional Studies , Female , Humans , Intention , Male , Middle Aged , Multivariate Analysis , SARS-CoV-2/immunology , Sex Factors , Vaccination/statistics & numerical data , Vaccination Hesitancy/statistics & numerical data
2.
Int J Infect Dis ; 105: 608-616, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33684559

ABSTRACT

OBJECTIVES: To investigate risk factors for persistent arthralgia in patients with chikungunya, and describe its impact on daily activities. METHODS: From September 2014 to July 2016, a surveillance study enrolled patients with acute febrile illness in Salvador, Brazil, and detected those with chikungunya virus infection using IgM enzyme-linked immunosorbent assay or reverse transcriptase polymerase chain reaction. Telephone follow-ups were performed to ascertain the progression of disease. RESULTS: Of 153 followed cases, 65 (42.5%) reported chronic arthralgia that lasted >3 months, and 47 (30.7%) were still symptomatic at the time of the interview (approximately 1.5 years after symptom onset). Limitations in daily activities and mental distress were reported by 93.8% and 61.5% of those with chronic arthralgia, respectively. Female sex [risk ratio (RR) 1.79, 95% confidence interval (CI) 1.95-2.69] and age (RR 1.02 for each 1-year increase, 95% CI 1.01-1.03) were independent risk factors for chronic arthralgia. Chronic arthralgia was not associated with co-infection with dengue virus (RR 0.97, 95% CI 0.48-1.94) or chikungunya viral load at diagnosis (median chikungunya virus RNA of 5.60 and 5.52 log10 copies/µL for those with and without chronic arthralgia, respectively; P = 0.75). CONCLUSIONS: These findings reinforce the high frequency of chronic chikungunya arthralgia, and highlight the substantial disability associated with the persistence of pain. Development of novel strategies to mitigate the transmission of chikungunya virus and to provide long-term medical assistance for patients with chikungunya are needed urgently.


Subject(s)
Arthralgia/epidemiology , Chikungunya Fever/epidemiology , Chikungunya virus/immunology , Chronic Pain/epidemiology , Adolescent , Adult , Arthralgia/etiology , Arthralgia/virology , Brazil/epidemiology , Chikungunya Fever/complications , Chikungunya Fever/virology , Chikungunya virus/genetics , Child , Child, Preschool , Chronic Pain/etiology , Chronic Pain/virology , Cohort Studies , Enzyme-Linked Immunosorbent Assay , Female , Humans , Infant , Male , Middle Aged , Odds Ratio , Risk Factors , Young Adult
3.
PLoS One ; 14(3): e0213301, 2019.
Article in English | MEDLINE | ID: mdl-30840708

ABSTRACT

BACKGROUND: Rapid diagnosis tests (RDTs) are easy to carry out, provide fast results, and could potentially guide medical treatment decisions. We investigated the performance of a commercially available RDT, which simultaneously detects the non-structural 1 (NS1) dengue virus (DENV) antigen, and IgM and IgG DENV antibodies, using representative serum samples from individuals in a dengue endemic area in Salvador, Brazil. METHODOLOGY/PRINCIPAL FINDINGS: We evaluated the accuracy of the SD BIOLINE Dengue Duo RDT (Abbott, Santa Clara, USA; former Alere Inc, Waltham, USA) in a random collection of sera. Samples included acute-phase sera from 246 laboratory-confirmed dengue cases and 108 non-dengue febrile patients enrolled in a surveillance study for dengue detection, 73 healthy controls living in the same surveillance community, and 73 blood donors. RDT accuracy was blindly assessed based on the combined results for the NS1 and the IgM test components. The RDT sensitivity was 46.8% (38.6% for the NS1 component and 13.8% for the IgM component). Sensitivity was greater for samples obtained from patients with secondary DENV infections (49.8%) compared to primary infections (31.1%) (P: 0.02) and was also influenced by the result in the confirmatory dengue diagnostic test, ranging from 39.7% for samples of cases confirmed by IgM-ELISA seroconversion between paired samples to 90.4% for samples of cases confirmed by a positive NS1-ELISA. The RDT specificity was 94.4% for non-dengue febrile patients, 87.7% for the community healthy controls, and 95.9% for the blood donors. CONCLUSIONS/SIGNIFICANCE: The SD BIOLINE Dengue Duo RDT showed good specificities, but low sensitivity, suggesting that it may be more useful to rule in than to rule out a dengue diagnosis in dengue endemic regions.


Subject(s)
Antibodies, Viral/blood , Dengue Virus/immunology , Dengue/diagnosis , Dengue/immunology , Point-of-Care Systems , Reagent Kits, Diagnostic/statistics & numerical data , Viral Nonstructural Proteins/immunology , Adolescent , Adult , Aged , Antibodies, Viral/immunology , Brazil/epidemiology , Case-Control Studies , Child , Dengue/epidemiology , Female , Follow-Up Studies , Humans , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Male , Middle Aged , Prognosis , Prospective Studies , ROC Curve , Young Adult
4.
PLoS Negl Trop Dis ; 11(1): e0005334, 2017 01.
Article in English | MEDLINE | ID: mdl-28114414

ABSTRACT

BACKGROUND: Chikungunya virus (CHIKV) entered Brazil in 2014, causing a large outbreak in Feira de Santana, state of Bahia. Although cases have been recorded in Salvador, the capital of Bahia, located ~100 km of Feira de Santana, CHIKV transmission has not been perceived to occur epidemically, largely contrasting with the Zika virus (ZIKV) outbreak and ensuing complications reaching the city in 2015. METHODOLOGY/PRINCIPAL FINDINGS: This study aimed to determine the intensity of CHIKV transmission in Salvador between November 2014 and April 2016. Results of all the CHIKV laboratory tests performed in the public sector were obtained and the frequency of positivity was analyzed by epidemiological week. Of the 2,736 tests analyzed, 456 (16.7%) were positive. An increasing in the positivity rate was observed, starting in January/2015, and peaking at 68% in August, shortly after the exanthematous illness outbreak attributed to ZIKV. CONCLUSIONS/SIGNIFICANCE: Public health authorities and health professionals did not immediately detect the increase in CHIKV cases, likely because all the attention was directed to the ZIKV outbreak and ensuing complications. It is important that regions in the world that harbor arbovirus vectors and did not experience intense ZIKV and CHIKV transmission be prepared for the potential co-emergence of these two viruses.


Subject(s)
Chikungunya Fever/virology , Chikungunya virus/isolation & purification , Zika Virus Infection/virology , Zika Virus/physiology , Brazil/epidemiology , Chikungunya Fever/epidemiology , Chikungunya virus/genetics , Chikungunya virus/physiology , Disease Outbreaks , Humans , Public Health , Seasons , Zika Virus/genetics , Zika Virus/isolation & purification , Zika Virus Infection/epidemiology
6.
Salvador; s.n; 2016. 79 p. ilus, tab.
Thesis in Portuguese | LILACS | ID: biblio-1001016

ABSTRACT

INTRODUÇÃO: O câncer do colo do útero é uma doença que apresenta um alto potencial de cura quando diagnosticado e tratado precocemente. Entretanto, sua morbimortalidade em todo o mundo ainda é elevada, constituindo-se um grande problema de Saúde Pública. O diagnóstico tardio desta neoplasia e o atraso no início do tratamento são fatores que comprometem a sobrevivência das mulheres acometidas. Assim, os determinantes para o retardo no atendimento especializado e no início do tratamento precisam ser melhor compreendidos para a efetiva assistência a essas mulheres. OBJETIVO: Descrever as características demográficas, socioeconômicas, clínicas e relacionadas ao acesso a serviços de saúde de mulheres com câncer do colo do útero e investigar a associação destas características com o retardo para um atendimento especializado e para o início do tratamento. METODOLOGIA: Trata-se de um estudo de coorte onde foram incluídas mulheres com câncer do colo do útero atendidas no Hospital Aristides Maltez, no período de 2011 a 2014...


INTRODUCTION: Cervical cancer is a disease that presents a high potential of cure when is diagnosed and treated early. However, their morbidity and mortality worldwide is still high, becoming a major public health problem. The late diagnosis of this tumor and the delay in the start of treatment are factors that compromise the survival of affected women. Thus, the decisive for the delay in specialized care and early treatment need to be better understood for effective assistance to these women. OBJECTIVE: To describe the demographic, socioeconomic , clinical and the access to health care characteristcs of women with cervical cancer and to investigate the association of these characteristics with the delay for specialized care and treatment initiation. METHODOLOGY: This is a cohort study where were included women with cervical cancer treated at Hospital Aristides Maltez, from 2011 to 2014...


Subject(s)
Humans , Cervix Uteri/anatomy & histology , Cervix Uteri/surgery , Cervix Uteri/cytology , Cervix Uteri/injuries , Cervix Uteri/pathology , Neoplasms/diagnosis , Neoplasms/immunology , Neoplasms/pathology , Neoplasms/radiotherapy
7.
PLoS Negl Trop Dis ; 9(7): e0003937, 2015.
Article in English | MEDLINE | ID: mdl-26196686

ABSTRACT

BACKGROUND: Few studies of dengue have shown group-level associations between demographic, socioeconomic, or geographic characteristics and the spatial distribution of dengue within small urban areas. This study aimed to examine whether specific characteristics of an urban slum community were associated with the risk of dengue disease. METHODOLOGY/PRINCIPAL FINDINGS: From 01/2009 to 12/2010, we conducted enhanced, community-based surveillance in the only public emergency unit in a slum in Salvador, Brazil to identify acute febrile illness (AFI) patients with laboratory evidence of dengue infection. Patient households were geocoded within census tracts (CTs). Demographic, socioeconomic, and geographical data were obtained from the 2010 national census. Associations between CTs characteristics and the spatial risk of both dengue and non-dengue AFI were assessed by Poisson log-normal and conditional auto-regressive models (CAR). We identified 651 (22.0%) dengue cases among 2,962 AFI patients. Estimated risk of symptomatic dengue was 21.3 and 70.2 cases per 10,000 inhabitants in 2009 and 2010, respectively. All the four dengue serotypes were identified, but DENV2 predominated (DENV1: 8.1%; DENV2: 90.7%; DENV3: 0.4%; DENV4: 0.8%). Multivariable CAR regression analysis showed increased dengue risk in CTs with poorer inhabitants (RR: 1.02 for each percent increase in the frequency of families earning ≤1 times the minimum wage; 95% CI: 1.01-1.04), and decreased risk in CTs located farther from the health unit (RR: 0.87 for each 100 meter increase; 95% CI: 0.80-0.94). The same CTs characteristics were also associated with non-dengue AFI risk. CONCLUSIONS/SIGNIFICANCE: This study highlights the large burden of symptomatic dengue on individuals living in urban slums in Brazil. Lower neighborhood socioeconomic status was independently associated with increased risk of dengue, indicating that within slum communities with high levels of absolute poverty, factors associated with the social gradient influence dengue transmission. In addition, poor geographic access to health services may be a barrier to identifying both dengue and non-dengue AFI cases. Therefore, further spatial studies should account for this potential source of bias.


Subject(s)
Dengue/epidemiology , Poverty Areas , Adolescent , Adult , Brazil/epidemiology , Child , Female , Humans , Male , Risk Factors , Socioeconomic Factors , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...